Cargando…

Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?

OBJECTIVE: To evaluate the relationship between age at seizure onset and neurodevelopmental outcome at age 24 months in infants with TSC, as well as the effect on neurodevelopmental outcome of early versus conventional treatment of epileptic seizures with vigabatrin (80–150 mg/kg/day). METHODS: Infa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moavero, Romina, Kotulska, Katarzyna, Lagae, Lieven, Benvenuto, Arianna, Emberti Gialloreti, Leonardo, Weschke, Bernhard, Riney, Kate, Feucht, Martha, Krsek, Pavel, Nabbout, Rima, Jansen, Anna C., Wojdan, Konrad, Borkowska, Julita, Sadowski, Krzysztof, Hertzberg, Christoph, Van Schooneveld, Monique M., Samueli, Sharon, Maulisovà, Alice, Aronica, Eleonora, Kwiatkowski, David J., Jansen, Floor E., Jozwiak, Sergiusz, Curatolo, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448162/ https://www.ncbi.nlm.nih.gov/pubmed/32705817 http://dx.doi.org/10.1002/acn3.51128

Ejemplares similares

Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study
por: Moavero, Romina, et al.
Publicado: (2019)

Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
por: Kotulska, Katarzyna, et al.
Publicado: (2020)

Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics
por: De Ridder, Jessie, et al.
Publicado: (2020)

miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex
por: Scheper, Mirte, et al.
Publicado: (2022)

Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years
por: Huschner, Franz, et al.
Publicado: (2023)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
por: Sadowski, Krzysztof, et al.
Publicado: (2022)

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
por: Mühlebner, Angelika, et al.
Publicado: (2020)

Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
por: Słowińska, Monika, et al.
Publicado: (2018)

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
por: Kotulska, Katarzyna, et al.
Publicado: (2014)

Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
por: Mills, James D., et al.
Publicado: (2017)

Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period
por: Korotkov, Anatoly, et al.
Publicado: (2022)

Author Correction: Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
por: Mills, James D., et al.
Publicado: (2022)

Epilepsy and Language Development in 8–36-Month-Old Toddlers with Tuberous Sclerosis Complex
por: Foryś-Basiejko, Małgorzata, et al.
Publicado: (2022)

MicroRNA‐34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis
por: Korotkov, Anatoly, et al.
Publicado: (2021)

Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2016)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas
por: Bongaarts, Anika, et al.
Publicado: (2020)

Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents – A questionnaire-based study
por: Moavero, Romina, et al.
Publicado: (2023)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Using Machine Learning to Explore Shared Genetic Pathways and Possible Endophenotypes in Autism Spectrum Disorder
por: Di Giovanni, Daniele, et al.
Publicado: (2023)

Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2019)

Autism Spectrum Disorder: Why Do We Know So Little?
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2018)

PPFIA4 mutation: A second hit in POLG related disease?
por: Sourbron, Jo, et al.
Publicado: (2021)

Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro
por: Bongaarts, Anika, et al.
Publicado: (2020)

Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase
por: Malik, Anna R., et al.
Publicado: (2015)

Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries
por: Jurkiewicz, Elzbieta, et al.
Publicado: (2015)

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
por: Gao, Chao, et al.
Publicado: (2023)

A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report
por: Auvin, Stéphane, et al.
Publicado: (2019)

Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)
por: Fuso, A., et al.
Publicado: (2016)

Predictors of Emergency Room Access and Not Urgent Emergency Room Access by the Frail Older Adults
por: Gentili, Susanna, et al.
Publicado: (2021)

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration
por: Jakubowska, Justyna, et al.
Publicado: (2021)

Newborn screening and gene therapy in SMA: Challenges related to vaccinations
por: Kotulska, Katarzyna, et al.
Publicado: (2022)

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update
por: Boon, Paul, et al.
Publicado: (2020)

Does the Coronavirus (COVID-19) Pandemic Call for a New Model of Older People Care?
por: Palombi, Leonardo, et al.
Publicado: (2020)

Alemtuzumab and intrathecal methotrexate failed in the therapy of Rasmussen encephalitis
por: Liba, Zuzana, et al.
Publicado: (2017)

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
por: Bongaarts, Anika, et al.
Publicado: (2017)

MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas
por: Bongaarts, Anika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kgqggvup33s2b3iqnj5gsnap5p